Zenas Biopharma (ZBIO) PT Raised to $34 at Morgan Stanley
Tweet Send to a Friend
Morgan Stanley analyst Sean Laaman raised the price target on Zenas Biopharma (NASDAQ: ZBIO) to $34.00 (from $31.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
